A Randomized, Controlled, Double Blind clinical study to evaluate use of Hydron Alkaline Ionized Water (HAIW) in healthy participants - NI

Hydron Alkaline Aqua Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.Healthy Male and Female participants in the age group of 21-40 Years
•2.Subjects of female gender or non-pregnant, non-lactating females. A urine pregnancy test is required for all female subjects of childbearing potential unless female subject has had a hysterectomy, tubal ligation, or is greater than 2 years postmenopausal.
•3.Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

•1.Known cases of any Severe and Chronic disease.
•2.Known subject of any active malignancy.
•3.Subjects giving history of significant cardiovascular event less than 12 weeks prior to randomization.
•4.Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
•5.Known subjects of having active metabolic or gastrointestinal diseases that may interfere with nutrient absorption, metabolism, or excretion, excluding diabetes.
•6.Subjects with Diabetes and Hypertension
•7.Subjects using any other investigational drug within 1 month prior to recruitment.
•8.Known hypersensitivity to alkaline water
•9.Pregnant and Lactating females.
•10.Subjects currently participating in any other Clinical study.
•11.Any other condition due to which patients are deemed to be unsuitable by the investigator for reason(s) not specifically started in the exclusion criteria.

发起方

Hydron Alkaline Aqua Pvt. Ltd.